Display options
Cite
Müllerova H, Gelhorn H, Wilson H, et al. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database. Chronic Obstr Pulm Dis. 2017;4(2):141-149doi: 10.15326/jcopdf.4.2.2017.0131.
Müllerova, H., Gelhorn, H., Wilson, H., Benson, V. S., Karlsson, N., Menjoge, S., Rennard, S. I., Tabberer, M., Tal-Singer, R., Merrill, D., & Jones, P. W. (2017). St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database. Chronic obstructive pulmonary diseases (Miami, Fla.), 4(2), 141-149. https://doi.org/10.15326/jcopdf.4.2.2017.0131
Müllerova, Hana, et al. "St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database." Chronic obstructive pulmonary diseases (Miami, Fla.) vol. 4,2 (2017): 141-149. doi: https://doi.org/10.15326/jcopdf.4.2.2017.0131
Müllerova H, Gelhorn H, Wilson H, Benson VS, Karlsson N, Menjoge S, Rennard SI, Tabberer M, Tal-Singer R, Merrill D, Jones PW. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database. Chronic Obstr Pulm Dis. 2017 Mar 28;4(2):141-149. doi: 10.15326/jcopdf.4.2.2017.0131. PMID: 28848923; PMCID: PMC5559113.
Copy Download .nbib Format: NLM
Share it on

Chronic Obstr Pulm Dis. 2017 Mar 28;4(2):141-149. doi: 10.15326/jcopdf.4.2.2017.0131.

St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.

Chronic obstructive pulmonary diseases (Miami, Fla.)

Hana Müllerova, Heather Gelhorn, Hilary Wilson, Victoria S Benson, Niklas Karlsson, Shailendra Menjoge, Stephen I Rennard, Maggie Tabberer, Ruth Tal-Singer, Debora Merrill, Paul W Jones

Affiliations

  1. Research and Development, GlaxoSmithKline, Uxbridge, United Kingdom.
  2. Evidera, Bethesda, Maryland.
  3. Research and Development, AstraZeneca, Gothenburg, Sweden.
  4. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
  5. Division of Pulmonary, Critical Care, Sleep and Allergy, Nebraska Medical Center, Omaha.
  6. AstraZeneca, Cambridge, United Kingdom.
  7. Respiratory Therapy Area Unit, Research and Development, GlaxoSmithKline, King of Prussia, Pennsylvania.
  8. COPD Foundation, Washington, D.C.
  9. Institute of Infection and Immunity, St George's University of London, United Kingdom.

PMID: 28848923 PMCID: PMC5559113 DOI: 10.15326/jcopdf.4.2.2017.0131

[No abstract available.]

Keywords: CBQC; COPD Biomarkers Qualification Consortium; COPD outcomes; SGRQ; St George’s Respiratory Questionnaire; predictive validity

Conflict of interest statement

HM, VSB, MT, RTS, PWJ, NK, SM and SIR are employees of the pharma companies who funded this analysis. SIR is an employee of the University of Nebraska Medical Center. HG and HW participated in this pr

References

  1. COPD. 2012 Apr;9(2):131-41 - PubMed
  2. Am J Respir Crit Care Med. 2012 May 15;185(10):1065-72 - PubMed
  3. Circulation. 2002 Jul 2;106(1):43-9 - PubMed
  4. Eur Respir J. 2009 Sep;34(3):648-54 - PubMed
  5. Eur Respir J. 2015 May;45(5):1239-47 - PubMed
  6. J Am Coll Cardiol. 2006 Feb 21;47(4):752-6 - PubMed
  7. Diabetes Care. 2014;37(3):694-700 - PubMed
  8. COPD. 2005 Mar;2(1):75-9 - PubMed
  9. Chest. 2015 Apr;147(4):999-1007 - PubMed
  10. Chest. 2015 May;147(5):1199-201 - PubMed
  11. COPD. 2013 Jun;10 (3):367-77 - PubMed
  12. Respir Med. 2014 Apr;108(4):600-8 - PubMed
  13. Respir Res. 2011 May 31;12:71 - PubMed
  14. Respir Med. 2011 Jan;105(1):57-66 - PubMed
  15. JAMA. 1999 Apr 14;281(14):1298-303 - PubMed
  16. Chest. 2015 Jan;147(1):31-45 - PubMed
  17. N Engl J Med. 2010 Sep 16;363(12):1128-38 - PubMed

Publication Types